Weight loss drugs could slash cancer risks by 41% compared to surgery, researchers claim
Weight loss drugs could slash cancer risks by 41% compared to surgery, researchers claim
Cikk tartalma röviden
New research suggests that weight loss drugs like Saxena and Trulicity may help reduce the risk of obesity-related cancers, which are linked to 13 types of cancer. A study compared patients who underwent bariatric surgery with those taking GLP-1 receptor agonists, finding that the drugs could be 41% more effective at preventing these cancers. However, the study has limitations, including a small number of diagnosed cases and the need for larger trials to confirm these findings.
New research suggests that weight loss drugs like Saxena and Trulicity may help reduce the risk of obesity-related cancers, which are linked to 13 types of cancer. A study compared patients who underwent bariatric surgery with those taking GLP-1 receptor agonists, finding that the drugs could be 41% more effective at preventing these cancers. However, the study has limitations, including a small number of diagnosed cases and the need for larger trials to confirm these findings.